Clinical Trial Update: RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures [NA]

View source ↗

Summary

RESTORE is a clinical trial evaluating AGN1 LOEP to prevent secondary hip fractures in patients with fragility fractures and osteoporosis. The study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• AGN1 LOEP

Snippet

Sponsor: AgNovos Healthcare, LLC | Conditions: Fragility Fracture, Hip Fractures | NA | Status: RECRUITING